Editorial draft — not for publication yet. Tramadol content needs review by a qualified UK healthcare professional before publication. For advice about your own prescription, contact your prescriber or pharmacist.
Quick answer
NICE describes chronic pain as pain that persists or recurs for more than 3 months. It distinguishes chronic primary pain—where no underlying condition adequately accounts for the pain or its impact—from chronic secondary pain linked to an underlying condition. These categories can coexist and need a person-centred assessment.
First distinguish chronic primary pain from other chronic pain
NICE advises not to initiate opioids, including tramadol, to manage chronic primary pain in people aged 16 and over. Other chronic pain conditions have separate recommendations, so this statement should not be applied to every person with long-term pain.
If you already take tramadol, seek a review—not an abrupt stop
The NICE recommendation is about starting opioids for chronic primary pain. It does not mean a person with an existing prescription should stop suddenly. A clinician can review the diagnosis, what benefit you experience, side effects, dose history, other treatments, and your preferences.
If you and the prescriber decide to reduce or stop regular tramadol, agree an individual plan. NICE guidance generally recommends a gradual, stepwise opioid reduction, adjusted to the person’s response and reviewed over time.
Make the review about pain, function, and goals
Describe how pain affects movement, sleep, mood, work, and daily tasks, as well as what tramadol changes. Ask what outcomes would show continued benefit and what options are supported for the diagnosed condition.
Seek prompt care for a major change in symptoms or new neurological signs. For a routine review, bring your medicines list and any previous attempts to change treatment so the plan can account for what has and has not worked.
A shared review should not reduce pain to a single score
NICE recommends assessing how chronic pain affects a person’s life and agreeing a care plan together. Describe changes in walking, sleep, mood, work, relationships, and daily activities, not only a number for pain intensity.
The plan can clarify whether tramadol has a meaningful benefit, what risks or side effects matter, and what other support is available for the underlying condition. Reviews should be respectful and recognise that people’s experiences of pain differ.
If a reduction is agreed, keep support in place
A tramadol reduction should not leave the original pain problem unaddressed. NICE guidance says to continue managing the underlying condition during withdrawal where needed, and to adjust the reduction plan if symptoms are difficult.
Agree who will review you, when the next contact will happen, and what to do if pain or withdrawal symptoms worsen. Seek urgent assessment for a major change in symptoms or new neurological signs.
Need help in the UK? Call 999 for a life-threatening emergency. For urgent medical advice that is not an emergency, contact NHS 111. Ask a pharmacist or prescriber about your specific medicine.
Frequently asked questions
Does NICE say not to use tramadol for all chronic pain?
No. NICE says not to initiate opioids for chronic primary pain. Chronic secondary pain has condition-specific guidance, so the diagnosis matters.
I already take tramadol for chronic pain—should I stop?
Do not stop suddenly. Arrange a shared review of your diagnosis, benefits and risks, and discuss a safe plan if a change is appropriate.
What is chronic primary pain?
NICE describes it as chronic pain where no underlying condition adequately accounts for the pain or its impact. A clinician should assess the type and cause of pain.
What should I prepare for a tramadol review?
Bring a medicine list and note the effects on pain, function, sleep, and side effects, plus any past attempts to reduce or change treatment.
Sources and further reading
This page is based on the following UK sources. Check the leaflet supplied with your own product, as advice can differ between formulations.
- NICE: Chronic pain: recommendations
- NICE: Medicines associated with dependence or withdrawal: recommendations
- NICE: Neuropathic pain in adults: recommendations
- NHS: How and when to take tramadol
Editorial status: Editorial draft — clinical review required before publication. Sources checked on 2 October 2026.
Related information
Read the Tramadol overview or continue to another topic: